Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents



Status:Completed
Conditions:Ovarian Cancer, Insomnia Sleep Studies, Women's Studies, Endocrine, Pulmonary
Therapuetic Areas:Endocrinology, Oncology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Reproductive
Healthy:No
Age Range:13 - 21
Updated:4/21/2018
Start Date:February 2012
End Date:June 2015

Use our guide to learn which trials are right for you!

Polycystic ovary syndrome (PCOS) is one of the most common disease caused by hormonal
imbalance and is also associated with overweight and obesity. It affects 5-10% of adolescent
girls and women capable of having children. Polycystic ovary syndrome is associated with
missed menstrual periods, hormonal imbalance, being overweight, and with a form of diabetes.
Girls with polycystic ovary syndrome may have a breathing problem known as "sleep apnea."
Sleep apnea may cause a person to stop breathing for short periods of time while sleeping.
People with polycystic ovary syndrome are thirty times more likely to develop sleep apnea
than those who do not have PCOS. If sleep apnea is not treated, it may lead to daytime
sleepiness, poor school performance, high blood pressure, heart disease and diabetes. The
purpose of this study is to understand how insulin function is affected in presence of sleep
apnea in girls with polycystic ovary syndrome between 13-21 years of age as compared to girls
with PCOS without sleep apnea. Insulin is one of the hormones made in your body to convert
food into energy. In people with increase weight body cannot use insulin properly. The
investigators also want to see if insulin action is also affected by sleep apnea.

See above.

Inclusion Criteria:

- Female.

- Ages 13-21

- PCOS

- BMI >95%ile (Obese group) or <85%ile (Lean group)

- Controls: ages 18-21, regular menses, BMI <85%ile

Exclusion Criteria:

- Breastfeeding.

- Pregnant.

- Use of any steroid preparations (including hormonal contraception), medications known
to alter insulin secretion and/or action within 3 month (including Metformin)
We found this trial at
1
site
Bronx, New York 10467
?
mi
from
Bronx, NY
Click here to add this to my saved trials